Delivery Order SPE2DB20D2104-SPE2DB26FMAYU
- Not listed
- The Defense Logistics Agency awarded a $1,001.17 delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vials with diluents, with a completion date of June 2, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $22,966.57 delivery order for Vivitrol 380 mg vial-diluents, with a completion date of August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger pharmaceutical supply agreements with DLA. The pharmaceutical products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,730.90 on October 27, 2025, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 28, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $18,442.74 delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents, with an ultimate completion date of September 29, 2025. This non-competitive award was issued on September 26, 2025, under a firm fixed-price contract type. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,017.66 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. The contract, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, operates under firm fixed price terms with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,002.34 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial with diluents. This contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vivitrol is a medication used in the treatment of opioid and alcohol use...
- The Defense Logistics Agency awarded a $2,002.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vials with diluents, with an ultimate completion date of June 30, 2025. This non-set-aside award was issued on June 27, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Vivitrol 380 mg vials with diluents, valued at $4,004.64. This non-set-aside contract represents a firm fixed-price delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $14,758.51 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $3,003.48 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Vivitrol 380 mg vial-diluents. This is a firm fixed-price contract with an ultimate completion date of October 23, 2025, and represents a non-competitive, non-set-aside award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMAYUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents, valued at $1,269.91. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by October 28, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen serves as a primary pharmaceutical distributor for federal medical procurement, supplying critical medications and medical supplies to support military and veteran healthcare systems. Vivitrol (naltrexone) is an FDA-approved medication used in the treatment of opioid and alcohol use disorders, making this procurement essential for the Defense Health Agency's substance use disorder treatment programs. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains, positioning it as a key vendor for military healthcare operations and Defense Logistics Agency medical supply chain management.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 10/27/25 |